Search

everythinglearnresearchcommunity

for

Search:↓

Scientists discovered a unique hair protein, KAP24.1, with a special structure, found only in the upper part of hair cuticles.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Androgens increase growth factors in skin cells, which may lead to acne.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Nilotinib can cause generalized keratosis pilaris.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Some hair protein genes evolved early and were adapted for use in hair follicles.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Polymeric nanoparticles show promise for treating skin diseases.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Certain genes and pathways are linked to the production of finer and denser wool in Hetian sheep.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Immune changes and specific genes contribute to male hair loss.

The method identified and measured ten compounds from Eclipta prostrata, showing significant enzyme inhibitory effects.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Researchers mapped and categorized specific keratin-associated protein genes on human chromosome 21q22.1.

The 3D structure of a key hair protein was modeled, revealing specific helical structures and stabilization features.